AUTHORS
L. Golob1, E.L. Williams1, M. Bras1, B. Clifton2, N. Ford3, E. Geng4, K.E. Green5, R. Janamnuaysook6, I. Katz7, L. Mworeko8, R.A. Olete9,10, C. Pinto3, R. Rajasuriar11, K. Sikombe12, D.H. Tan13, B. Grinsztejn14
INSTITUTIONS
1International AIDS Society, HIV Programmes & Advocacy, Geneva, Switzerland, 2National Association of People with HIV Australia, Newtown, Australia, 3World Health Organization (WHO), Department of HIV, Hepatitis and STIs, Geneva, Switzerland, 4Washington University School of Medicine in St. Louis, St. Louis, United States, 5PATH, Geneva, Switzerland, 6Institute of HIV Research and Innovation, Bangkok, Thailand, 7President's Emergency Plan for AIDS Relief, Bureau of Global Health Security and Diplomacy, Washington D.C., United States, 8International Community of Women Living with HIV Eastern Africa, Kampala, Uganda, 9Sustained Health Initiatives of the Philippines Inc, Mandaluyong City, Philippines, the, 10National Cheng Kung University, Department of Public Health, Tainan City, Taiwan, Province of China, 11University of Malaya, Centre of Excellence for Research in AIDS, Kuala Lumpur, Malaysia, 12Centre for Infectious Disease Research in Zambia, Lusaka, Zambia, 13St. Michael’s Hospital, Division of Infectious Diseases, Toronto, Canada, 14Fiocruz, Instituto Nacional de Infectologia Evandro Chagas, Rio de Janeiro, Brazil
View the recommendations in detail here.
Learn more about the global stakeholder consultation series which informed this statement here.